论文部分内容阅读
目的 :探讨支气管哮喘应用小剂量糖皮质激素布地奈德吸入治疗的效果。方法 :选取我院2013年6月至2015年6月的38例支气管哮喘进行治疗分析,随机分为观察组和对照组各54例,对照组采用常规药物治疗,观察组采用茶碱类药物联合小剂量糖皮质激治疗,观察两组患者的治疗效果。结果:观察组的总有效率(94.7%)明显高于对照组(78.9%),具有统计学意义(P<0.05);观察组的气道阻力(Raw)和气道传导率(Gaw)明显优于对照组,具有统计学意义(P<0.05)。结论 :采用茶碱类药物联合小剂量糖皮质激治疗支气管哮喘可以更好的改善患者的症状,改善患者的气道阻力和气道传导率,具有重要临床意义。
Objective: To investigate the effect of inhaled low dose glucocorticoid budesonide in bronchial asthma. Methods: Thirty-eight patients with bronchial asthma were selected from June 2013 to June 2015 in our hospital. The patients were randomly divided into observation group (54 cases) and control group (54 cases). The control group was treated with conventional drugs. The observation group was treated with theophylline combination Small doses of glucocorticoid therapy, the treatment of two groups were observed. Results: The total effective rate (94.7%) in the observation group was significantly higher than that in the control group (78.9%), with statistical significance (P <0.05). The observation group had significantly better airway resistance and Gaw In the control group, with statistical significance (P <0.05). Conclusion: Theophylline combined with low-dose glucocorticoid therapy for bronchial asthma can improve the symptoms of patients and improve the airway resistance and airway conduction. It is of great clinical significance.